Generic Name: Canakinumab
Brand Name: Ilaris
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Indications: Cryopyrin-Associated Periodic Syndrome (CAPS)
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: January 26, 2011
Recommendation Type: Do not list